Oxfordshire, United Kingdom

John Barker




Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: John Barker: Innovator in Thromboembolic Disease Therapies

Introduction

John Barker is a notable inventor based in Oxfordshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit Factor XIa, which plays a crucial role in thromboembolic diseases. With a total of 2 patents to his name, Barker's work is paving the way for innovative therapies.

Latest Patents

Barker's latest patents include two key inventions. The first patent, titled "Pyrimidinone and its derivatives inhibiting factor XIa," provides compounds of the general formula (I), their salts, N-oxides, solvates, and prodrugs. These compounds are designed to inhibit Factor XIa, making them useful in the prevention and therapy of thromboembolic diseases. The second patent, "Pyridinone and pyrimidinone derivatives as factor XIa inhibitors," similarly offers compounds of the general formula (I) with the same therapeutic applications.

Career Highlights

John Barker is currently associated with Ono Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work focuses on developing new therapies that can significantly impact patient care in thromboembolic conditions.

Collaborations

Barker collaborates with esteemed colleagues, including Steve Courtney and Chris Yarnold, to advance research and development in his field. Their combined expertise enhances the potential for groundbreaking discoveries.

Conclusion

John Barker's contributions to the field of pharmaceuticals, particularly through his patents on Factor XIa inhibitors, highlight his role as an innovator in the prevention and treatment of thromboembolic diseases. His ongoing work promises to lead to significant advancements in medical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…